TWD
HRTX icon

True Wealth Design’s Heron Therapeutics HRTX Stock Holding History

True Wealth Design’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-271
Closed -$217 – 2763
2026
Q1 		$217 Buy
+271
New +$314 ﹤0.01% 2316
2025
Q3 		– Sell
-330
Closed -$684 – 2794
2025
Q2 		$684 Buy
330
+319
+2,900% +$651 ﹤0.01% 1613
2025
Q1 		$25 Buy
+11
New +$21 ﹤0.01% 2542
2024
Q4 		– Sell
-830
Closed -$1.65K – 1435
2024
Q3 		$1.65K Buy
+830
New +$1.98K ﹤0.01% 839

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

True Wealth Design's HRTX Position: Q2 2026 in Review

True Wealth Design sold out of Heron Therapeutics (HRTX) in Q2 2026, closing a stake of 271 shares — an estimated $217 sold.

True Wealth Design first reported a position in HRTX in Q3 2024 and held it in 4 quarters. The position peaked at $1.65K in Q3 2024. 162 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • True Wealth Design reported no remaining Heron Therapeutics position as of Q2 2026 after selling out during the quarter.
  • True Wealth Design sold 271 Heron Therapeutics shares in Q2 2026, an estimated $217.
  • True Wealth Design first reported a position in Heron Therapeutics in Q3 2024 and held it in 4 quarters.
  • True Wealth Design's Heron Therapeutics position peaked at $1.65K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.